Variant report
Variant | esv2374967 |
---|---|
Chromosome Location | chr8:103513738-103513739 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:37)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:37 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr8:103513411-103513751 | K562 | blood: | n/a | n/a |
2 | BHLHE40 | chr8:103513428-103513822 | K562 | blood: | n/a | n/a |
3 | CBX3 | chr8:103513286-103513807 | K562 | blood: | n/a | n/a |
4 | CEBPB | chr8:103513415-103513813 | K562 | blood: | n/a | n/a |
5 | CEBPB | chr8:103513442-103513823 | K562 | blood: | n/a | n/a |
6 | CEBPD | chr8:103513387-103513901 | K562 | blood: | n/a | n/a |
7 | CEBPD | chr8:103513303-103513873 | K562 | blood: | n/a | n/a |
8 | EGR1 | chr8:103513466-103513790 | K562 | blood: | n/a | n/a |
9 | EP300 | chr8:103513437-103513819 | K562 | blood: | n/a | n/a |
10 | GABPA | chr8:103513432-103513763 | K562 | blood: | n/a | n/a |
11 | GATA1 | chr8:103513224-103513933 | K562 | blood: | n/a | chr8:103513589-103513605 chr8:103513593-103513602 |
12 | GATA1 | chr8:103513491-103513783 | K562 | blood: | n/a | chr8:103513589-103513605 chr8:103513593-103513602 |
13 | GATA2 | chr8:103513378-103513794 | K562 | blood: | n/a | chr8:103513589-103513605 chr8:103513593-103513602 |
14 | GATA2 | chr8:103513361-103513821 | K562 | blood: | n/a | chr8:103513589-103513605 chr8:103513593-103513602 |
15 | GATA2 | chr8:103513386-103513791 | K562 | blood: | n/a | chr8:103513589-103513605 chr8:103513593-103513602 |
16 | HDAC2 | chr8:103513444-103513837 | K562 | blood: | n/a | n/a |
17 | JUND | chr8:103513378-103513755 | K562 | blood: | n/a | n/a |
18 | MAZ | chr8:103513473-103513793 | K562 | blood: | n/a | n/a |
19 | MYC | chr8:103513314-103513754 | K562 | blood: | n/a | n/a |
20 | NR2F2 | chr8:103513337-103514084 | K562 | blood: | n/a | n/a |
21 | NR2F2 | chr8:103513355-103513856 | K562 | blood: | n/a | n/a |
22 | PML | chr8:103513342-103513819 | K562 | blood: | n/a | n/a |
23 | PML | chr8:103513374-103513813 | K562 | blood: | n/a | n/a |
24 | POLR2A | chr8:103513509-103513777 | K562 | blood: | n/a | n/a |
25 | POLR2A | chr8:103513457-103513738 | K562 | blood: | n/a | n/a |
26 | RCOR1 | chr8:103513354-103513829 | K562 | blood: | n/a | n/a |
27 | RCOR1 | chr8:103513373-103513783 | K562 | blood: | n/a | n/a |
28 | STAT5A | chr8:103513324-103513837 | K562 | blood: | n/a | n/a |
29 | STAT5A | chr8:103513385-103513767 | K562 | blood: | n/a | n/a |
30 | TAL1 | chr8:103513331-103513849 | K562 | blood: | n/a | n/a |
31 | TBL1XR1 | chr8:103513436-103513772 | K562 | blood: | n/a | n/a |
32 | TEAD4 | chr8:103513301-103513863 | K562 | blood: | n/a | n/a |
33 | TEAD4 | chr8:103513346-103513822 | K562 | blood: | n/a | n/a |
34 | TRIM28 | chr8:103513301-103513802 | K562 | blood: | n/a | n/a |
35 | USF1 | chr8:103513527-103513772 | K562 | blood: | n/a | n/a |
36 | ZMIZ1 | chr8:103513443-103513790 | K562 | blood: | n/a | n/a |
37 | ZNF384 | chr8:103513600-103513777 | K562 | blood: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RPS12P15 | TF binding region |
ENSG00000240724 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs11313727 | chr8:103513738-103513739 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
small cell lung cancer | 20016488 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Bladder cancer | 19088036 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Cancer | 20164920 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Breast cancer | 20409316 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Breast cancer | 21611746 | CNVD |
Oral squamous cell carcinoma | 21853135 | CNVD |
Bladder cancer | 21909424 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:103502800-103529800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr8:103503000-103517400 | Weak transcription | H9 Cell Line | embryonic stem cell |
3 | chr8:103508800-103514600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr8:103508800-103517400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
5 | chr8:103509000-103517400 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
6 | chr8:103510000-103516000 | Weak transcription | Pancreas | Pancrea |
7 | chr8:103513200-103513800 | Enhancers | HepG2 | liver |
8 | chr8:103513200-103513800 | Enhancers | K562 | blood |